Cargando…

Disabling Cas9 by an anti-CRISPR DNA mimic

CRISPR (clustered regularly interspaced short palindromic repeats)–Cas9 gene editing technology is derived from a microbial adaptive immune system, where bacteriophages are often the intended target. Natural inhibitors of CRISPR-Cas9 enable phages to evade immunity and show promise in controlling Ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Jiyung, Jiang, Fuguo, Liu, Jun-Jie, Bray, Nicolas L., Rauch, Benjamin J., Baik, Seung Hyun, Nogales, Eva, Bondy-Denomy, Joseph, Corn, Jacob E., Doudna, Jennifer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507636/ https://www.ncbi.nlm.nih.gov/pubmed/28706995 http://dx.doi.org/10.1126/sciadv.1701620

Ejemplares similares

CRISPR-Cas9 bends and twists DNA to read its sequence
por: Cofsky, Joshua C., et al.
Publicado: (2022)

Nucleosome breathing and remodeling constrain CRISPR-Cas9 function
por: Isaac, R Stefan, et al.
Publicado: (2016)

Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system
por: Bondy-Denomy, Joe, et al.
Publicado: (2012)

CRISPR-Cas12a targeting of ssDNA plays no detectable role in immunity
por: Marino, Nicole D, et al.
Publicado: (2022)

Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair
por: Wienert, Beeke, et al.
Publicado: (2020)

Bacterial alginate regulators and phage homologs repress CRISPR-Cas immunity
por: Borges, Adair L., et al.
Publicado: (2020)

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
por: Farboud, Behnom, et al.
Publicado: (2018)

A New Group of Phage Anti-CRISPR Genes Inhibits the Type I-E CRISPR-Cas System of Pseudomonas aeruginosa
por: Pawluk, April, et al.
Publicado: (2014)

Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble
por: Liu, Tina Y., et al.
Publicado: (2019)

Active and adaptive Legionella CRISPR‐Cas reveals a recurrent challenge to the pathogen
por: Rao, Chitong, et al.
Publicado: (2016)

RNA-dependent RNA targeting by CRISPR-Cas9
por: Strutt, Steven C, et al.
Publicado: (2018)

Conformational control of DNA target cleavage by CRISPR–Cas9
por: Sternberg, Samuel H., et al.
Publicado: (2015)

Positioning Diverse Type IV Structures and Functions Within Class 1 CRISPR-Cas Systems
por: Taylor, Hannah N., et al.
Publicado: (2021)

DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
por: Sternberg, Samuel H., et al.
Publicado: (2014)

Programmable RNA recognition and cleavage by CRISPR/Cas9
por: O’Connell, Mitchell R., et al.
Publicado: (2014)

Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes
por: Watters, Kyle E., et al.
Publicado: (2020)

Decorating chromatin for enhanced genome editing using CRISPR-Cas9
por: Chen, Evelyn, et al.
Publicado: (2022)

A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9
por: Dagdas, Yavuz S., et al.
Publicado: (2017)

Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
por: Lee, Kunwoo, et al.
Publicado: (2017)

Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
por: Oakes, Benjamin L, et al.
Publicado: (2016)

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
por: Chen, Janice S., et al.
Publicado: (2017)

CRISPR/Cas9 microinjection in oocytes disables pancreas development in sheep
por: Vilarino, Marcela, et al.
Publicado: (2017)

CRISPR-Cas9 mediated one-step disabling of pancreatogenesis in pigs
por: Wu, Jun, et al.
Publicado: (2017)

Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
por: Lin, Steven, et al.
Publicado: (2014)

Mobile element warfare via CRISPR and anti-CRISPR in Pseudomonas aeruginosa
por: León, Lina M, et al.
Publicado: (2021)

Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering
por: Lee, Kunwoo, et al.
Publicado: (2017)

Imaging Unique DNA Sequences in Individual Cells Using a CRISPR-Cas9-Based, Split Luciferase Biosensor
por: Heath, Nicholas G., et al.
Publicado: (2022)

Foreign DNA acquisition by the I-F CRISPR–Cas system requires all components of the interference machinery
por: Vorontsova, Daria, et al.
Publicado: (2015)

RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis
por: Park, Jong-Jin, et al.
Publicado: (2017)

CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus
por: Panfil, Amanda R., et al.
Publicado: (2018)

Deciphering Off-Target Effects in CRISPR-Cas9 through Accelerated Molecular Dynamics
por: Ricci, Clarisse G., et al.
Publicado: (2019)

In vitro–transcribed guide RNAs trigger an innate immune response via the RIG-I pathway
por: Wienert, Beeke, et al.
Publicado: (2018)

Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2
por: Thavalingam, Annoj, et al.
Publicado: (2019)

A CRISPR-Cas9–integrase complex generates precise DNA fragments for genome integration
por: Jakhanwal, Shrutee, et al.
Publicado: (2021)

Evolution of CRISPR RNA recognition and processing by Cas6 endonucleases
por: Niewoehner, Ole, et al.
Publicado: (2014)

Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
por: Rose, John C., et al.
Publicado: (2020)

The solution structure of an anti-CRISPR protein
por: Maxwell, Karen L., et al.
Publicado: (2016)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Author Correction: CRISPR/Cas9 microinjection in oocytes disables pancreas development in sheep
por: Vilarino, Marcela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d29q8u5v5sfjkimvh8bjh3cuga